EICHOR
● Completed
A Study to Evaluate the Safety and Efficacy of NG101 in Adult Participants With Symptomatic Diabetic or Idiopathic Gastroparesis
Condition: Diabetic Gastroparesis · Idiopathic Gastroparesis · Sponsor: Neurogastrx, Inc.
About this study
The purpose of this study is to assess the safety and efficacy of various dose levels of NG101 compared with placebo in adult participants with gastroparesis during 12 weeks of treatment.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (83)
| Digestive Health Specialists | Dothan, Alabama, United States | — |
| G & L Research, LLC | Foley, Alabama, United States | — |
| East View Medical Research | Mobile, Alabama, United States | — |
| Phoenix Medical Group | Peoria, Arizona, United States | — |
| Phoenix Clinical LLC | Phoenix, Arizona, United States | — |
| Del Sol Research Management | Tucson, Arizona, United States | — |
| Preferred Research Partners | Little Rock, Arkansas, United States | — |
| GW Research, Inc | Chula Vista, California, United States | — |
| Precision Research Institute, LLC | Chula Vista, California, United States | — |
| Kindred Medical Institute for Clinical Trials, LLC | Corona, California, United States | — |
| Diagnamics Inc. | Encinitas, California, United States | — |
| Paragon Rx Clinical, Inc | Garden Grove, California, United States | — |
+ 71 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04303195